Schreiner Etiketten und Selbstklebetechnik GmbH & Co. – Trademark Portfolio
Entity Type: 03
Schreiner Etiketten und Selbstklebetechnik GmbH & Co. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include PHARMA-TAC and PHARMA-COMB. The owner is based in D-85764 Oberschleissheim.
Bruckmannring 22
D-85764 Oberschleissheim , DE
Showing of trademarks Trademarks
Trademark Classifications
Schreiner Etiketten und Selbstklebetechnik GmbH & Co.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Schreiner Etiketten und Selbstklebetechnik GmbH & Co. have?
Schreiner Etiketten und Selbstklebetechnik GmbH & Co. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Schreiner Etiketten und Selbstklebetechnik GmbH & Co. file in?
Schreiner Etiketten und Selbstklebetechnik GmbH & Co. files trademarks across 1 Nice Classification class. The most active classes are Class 16 (Paper Goods). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are Schreiner Etiketten und Selbstklebetechnik GmbH & Co.'s most well-known trademarks?
Schreiner Etiketten und Selbstklebetechnik GmbH & Co.'s registered trademark portfolio includes well-known marks such as PHARMA-TAC and PHARMA-COMB. These are among 2 currently registered trademarks in the portfolio.
What is Schreiner Etiketten und Selbstklebetechnik GmbH & Co.'s trademark registration success rate?
Schreiner Etiketten und Selbstklebetechnik GmbH & Co. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.